FR1643M - Médicament a base de complexes solubles dans l'eau, d'esters diglycériques naturels d'acide choline-phosphorique et de sels d'acides biliaires. - Google Patents

Médicament a base de complexes solubles dans l'eau, d'esters diglycériques naturels d'acide choline-phosphorique et de sels d'acides biliaires.

Info

Publication number
FR1643M
FR1643M FR880887A FR880887A FR1643M FR 1643 M FR1643 M FR 1643M FR 880887 A FR880887 A FR 880887A FR 880887 A FR880887 A FR 880887A FR 1643 M FR1643 M FR 1643M
Authority
FR
France
Prior art keywords
choline
salts
natural
water
phosphoric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR880887A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Natterman und Cie GmbH
Original Assignee
A Natterman und Cie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Natterman und Cie GmbH filed Critical A Natterman und Cie GmbH
Application granted granted Critical
Publication of FR1643M publication Critical patent/FR1643M/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C07F9/103—Extraction or purification by physical or chemical treatment of natural phosphatides; Preparation of compositions containing phosphatides of unknown structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
FR880887A 1960-12-05 1961-12-04 Médicament a base de complexes solubles dans l'eau, d'esters diglycériques naturels d'acide choline-phosphorique et de sels d'acides biliaires. Active FR1643M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEN19273A DE1141639B (de) 1960-12-05 1960-12-05 Verfahren zur Herstellung wasserloeslicher Cholinphosphorsaeure-diglyceridester-Verbindungen

Publications (1)

Publication Number Publication Date
FR1643M true FR1643M (fr) 1963-01-07

Family

ID=7340822

Family Applications (1)

Application Number Title Priority Date Filing Date
FR880887A Active FR1643M (fr) 1960-12-05 1961-12-04 Médicament a base de complexes solubles dans l'eau, d'esters diglycériques naturels d'acide choline-phosphorique et de sels d'acides biliaires.

Country Status (9)

Country Link
US (1) US3197368A (fr)
BE (1) BE610853A (fr)
CH (1) CH423766A (fr)
DE (1) DE1141639B (fr)
DK (1) DK130619B (fr)
FR (1) FR1643M (fr)
GB (1) GB953899A (fr)
NL (2) NL126750C (fr)
SE (1) SE310977B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1202370B (it) * 1976-07-12 1989-02-09 Hoffmann La Roche Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
DE3047048A1 (de) 1980-12-13 1982-07-29 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur abtrennung von oel und/oder phosphatidylethanolamin aus diese enthaltenden alkoholloeslichen phosphatidylcholin-produkten
DE3229179C2 (de) * 1982-08-05 1986-04-17 A. Nattermann & Cie GmbH, 5000 Köln Lungensurfactant
IL72420A (en) * 1983-07-22 1987-10-30 Hoffmann La Roche Aqueous vitamin e solutions and their manufacture
US4866044A (en) * 1985-07-09 1989-09-12 Takeda Chemical Industries, Ltd. Solubilized composition of poorly-soluble pharmaceutical product
JPS62106018A (ja) * 1985-11-01 1987-05-16 Santen Pharmaceut Co Ltd 高濃度ビタミンｅ水性製剤
CA1319886C (fr) * 1987-02-03 1993-07-06 Alberto Ferro Solutions de micelles mixtes
US7816492B2 (en) * 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
US20030017528A1 (en) * 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
ES2280435T3 (es) 2000-12-01 2007-09-16 Astellas Pharma Inc. Metodo de exploracion de remedios para la diabetes.
WO2004024943A1 (fr) * 2002-09-11 2004-03-25 Yamanouchi Pharmaceutical Co., Ltd. Procede de criblage d'un amplificateur de la teneur en insuline
EP1898931B1 (fr) * 2005-07-07 2014-12-31 Postech Foundation Modulateur de captage du glucose et procede de traitement du diabete et des complications du diabete
US8314080B2 (en) 2010-04-06 2012-11-20 Kuwait University Method of treating type I diabetes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2055083A (en) * 1932-07-13 1936-09-22 Winthrop Chem Co Inc Pharmaceutical preparation

Also Published As

Publication number Publication date
DE1141639B (de) 1962-12-27
SE310977B (fr) 1969-05-19
US3197368A (en) 1965-07-27
BE610853A (fr)
GB953899A (en) 1964-04-02
DK130619B (da) 1975-03-17
NL126750C (fr)
CH423766A (de) 1966-11-15
NL260444A (fr)
DK130619C (fr) 1975-08-25

Similar Documents

Publication Publication Date Title
FR1643M (fr) Médicament a base de complexes solubles dans l'eau, d'esters diglycériques naturels d'acide choline-phosphorique et de sels d'acides biliaires.
BE827905A (fr) Utilisation d'esters d'acide hydroxycarboxyliques aliphatiques en tant que desodorisants
BE752813A (fr) Preparation d'acide trans-chrysanthemique optiquement actif
BE802700A (fr) Nouvelles compositions pharmaceutiques a base d'acide glycyrrhetinique
FR2034785A1 (fr) Nucleoside-phosphonates,acides phosphoniques et sels d'acides phosphoniques correspondants ainsi que leurs intermediaires
FR1748M (fr) Médicament a base d'un amide d'acide benzoique substitué.
FR2886M (fr) Médicament a base de dérivés de l'acide anthranilique.
FR2960M (fr) Compositions, facilement dispersibles dans l'eau, a base d'ester d'acide gras de vitamine a.
FR3026M (fr) Médicament narcotique a base d'ester n-propylique de l'acide 3-méthoxy-4-n-éthyloxy-n-éthylcarbaminométhoxyphénylacétique.
FR1446M (fr) Un nouveau médicament, l'ester méthoxy-méthylique de l'acide 4-chloro-3-sulfamylbenzoique.
FR2323392A1 (fr) Esters d'acides furanose-o-pyridylcarboxyliques
BE747656A (fr) Compositions pharmaceutiques ameliorees comprenant un sel hydrosoluble d'un compose acide actif et un excipient hydrosoluble (
BE762162A (fr) Esters d'acide anthranilique nucleairement alcoyles
FR1250M (fr) Médicament a base d'acide n-(2,3-dichloro-6-méthylphényl) anthranilique et de ses sels pour combattre les états inflammatoires.
FR100M (fr) Médicament cholérétique a base d'acide 1-cétocyclododécyl-2-acétique.
FR3748M (fr) Compositions thérapeutiques antitussives, anti-inflammatoires et bronchodilatatrices a base de sels nouveaux des acides : 2,6-di-ter-butyl-naphtalene mono et di-sulfonique, et de l'acide théophyllinyl-7-acétique.
FR1093M (fr) Médicament a base de dérivé d'acide phénoxy-acétique.
FR1178M (fr) Médicament a base de dérivé d'acide glycyrrhetinique.
FR1402807A (fr) Procédé de préparation de complexes d'esters diglycériques naturels d'acide cholinephosphorique et de sels d'acides biliaires
FR2379M (fr) Médicament a base de dérivé d'acide acrylique.
FR2841M (fr) Médicament coronarodilatateur a base d'esters de l'acide mandélique.
FR3435M (fr) Médicament a base de nouveaux dérivés de l'acide 6-amino-pénicillanique.
FR1312M (fr) Médicament a base de dérivé de l'acide podophyllique.
FR1656M (fr) Médicament a base de sels d'addition de l'acide benzophénone-2-carboxylique et de la 1-méthyl-3-(di-2-thiénylméthylene)-pipéridine.
FR2316961A1 (fr) Saponine acide soluble dans l'eau